- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01934413
Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study (TPC)
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The purpose of the proposed research is to design and evaluate a technology enhanced transitional palliative care (TPC) intervention for patients living in rural locations. The contributions of the proposed research are expected to address the gap in palliative care services and transitions of care for rural patients. This research is significant because it addresses the challenges of three independently important health care foci - needs of rural patients, care transitions, and the evolving field of palliative care. The study will not simply address the critical barrier imposed by distance, but also extend PC practice by improving transition management for the impending dramatic increase in seriously ill and dying patients in rural areas through evolving demographic shifts. The goal of the proposed research is to advance the development of transitional care strategies for rural PC patients and caregivers, and provide evidence of new ways to support continuity of care for patients with life-limiting conditions.
The study is guided by the "Transitional Care Model" or "TCM" as developed by Naylor which combines quality, cost, and satisfaction. The TCM has a solid evidence base from more than 15 years of multidisciplinary research. Unique features of the model include care that is delivered and coordinated by the same nurse across hospital and home settings 7 days per week for an average of 2 to 3 months using evidence-based protocols with a focus on long term outcomes. Core components of the model include a holistic, person/family centered approach and protocol guided care. The nurse functions as part of an interdisciplinary team with shared accountability, however, the nurse is the single "point person" across an episode of care providing the vital link from hospital to home. Inherent within the model is shared communication systems that span care settings.
A randomized control trial design will be used. Community dwelling adult patients and their caregivers who receive a palliative care consult while hospitalized in the hospital will be enrolled in the study, then randomized to group membership and followed for a total of 8 weeks after hospital discharge. Following a detailed protocol for TPC, the intervention group will receive weekly video session visits (using computer software that allows audio/visual contact through the computer screen) by the study nurse. The investigators will determine the feasibility and acceptability of the TPC intervention and study methods and procedures when engaging palliative care patients and their caregivers. The investigators will compare patient and caregiver reported outcomes and determine effect size for patients receiving technology-enhanced TPC (intervention group) to patients in the control group, and they will explore the impact of the technology-enhanced TPC intervention on health care service utilization.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Minnesota
-
Mankato, Minnesota, Forente stater, 56001
- Mayo Health System
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adult patients hospitalized at study site, and their designated caregiver (if available)
- Receiving palliative care
- Returning home or to a facility for short term (30 days) rehabilitation
- Able to provide informed consent
- Able to complete self-reported questionnaires without assistance
Exclusion Criteria:
- Long-term placement in skilled nursing facility after hospitalization
- Receiving hospice
- Living within city limits of hospital
- Cognitive impairments
- Non-English speaking
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Technology-Enhanced TPC
In addition to receiving usual palliative care service in the hospital setting, Technology-Enhanced Transitional Palliative Care patients will receive Transitional Care from the Palliative Care consulting team beginning in the hospital within 24 hours of study enrollment and continuing post discharge for eight weeks in their homes in rural locations by means of video visits with the Palliative Care consulting team.
|
The Transitional Care intervention will be initiated within 24 hours after enrollment, and will include initial transitional care planning, daily hospital visits, crisis prevention planning by an experienced Palliative Care nurse.
The intervention will continue after the patient is discharged to home or short term skilled nursing facility, and it will involve an in-person visit between 24-48 hours post discharge, weekly virtual visits via iPad and video conference technology, and additional home visits as needed.
Care plans established during initial planning will be implemented and adjusted under the guidance of the palliative care nurse delivering the intervention.
|
Annen: Usual standard of care
The control group will receive only the current standard palliative care service in the hospital setting, which includes standard in-hospital palliative care consultation and standard discharge planning.
|
Usual care includes routine hospital discharge planning and usual physician care in primary and specialty outpatient clinics post hospital discharge.
The PC consulting service provides consulting services in the inpatient setting.
There are no standardized, intentional services provided to outpatients by the PC consulting team.
Services provided to outpatients may occur sporadically as initiated by the patient.
The majority of PC follow-up if any is a single phone call to the patient/caregiver.
To account for the time spent and number of contacts made with the intervention group, the control group will be contacted by phone weekly by a non-nurse member of the study team not involved with the intervention, asked to relate what, if any, medically-related events occurred.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in mean scores on FACIT-Pal Questionnaire
Tidsramme: Baseline, 1 month post-enrollment, 2 months post-enrollment
|
The patient's quality of life will be determined by the change in mean scores from baseline to 1 month and 2 months post enrollment, using the Functional Assessment of Chronic Illness Therapy - Palliative Care Scale (FACIT-Pal).
The FACIT-Pal palliative subscale contains 19 questions specific to persons with life-limiting illness.
Each item is rated on a 5 point numeric rating scale from 9 (not at all) to 4 (very much).
Scores range from 0-76.
Higher scores indicate better quality of life.
|
Baseline, 1 month post-enrollment, 2 months post-enrollment
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in mean scores on ESAS-r Questionnaire
Tidsramme: Baseline, 1 month post-enrollment, 2 months post-enrollment
|
The patient's symptom intensity will be determined by the change in mean scores from baseline to 1 month and 2 months post enrollment, as measured by the Edmonton Symptom Assessment System (revised) ESAS-r scale, The ESAS-r captures the patient's perspective on 9 symptoms that are common in palliative care (pain, tiredness, drowsiness, nausea, lack of appetite, shortness of breath, depression, anxiety, wellbeing).
An optional 10th symptom can be reported.
Each symptom is rated on an 11 point numeric rating scale from 0 (symptom absent or best) to 10 (worst possible).
Scores range from 0-100, with lower scores indicating patient perceives fewer or no symptoms and higher scores indicating patient perceives worse symptoms.
|
Baseline, 1 month post-enrollment, 2 months post-enrollment
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Health Care Service Utilization
Tidsramme: Baseline to 6 months after enrollment
|
Health Services information will be summarized by review of medical records and administrative databases for number of unplanned hospitalizations, number of intensive care unit days, total length of hospital stay (days), number of emergency department visits, number of clinic office visits, number of home healthcare visits, time (in days) to hospice admission, and time (days) receiving hospice.
|
Baseline to 6 months after enrollment
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Diane E Holland, PhD, RN, Mayo Clinic
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 13-006242
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Palliativ omsorg
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T terapikomplikasjonerItalia
-
Azienda Usl di BolognaIRCCS Azienda Ospedaliero-Universitaria di BolognaFullførtPalliativ omsorg | Palliativ medisin | Hospice og palliativ sykepleieItalia
-
The Lymphoma Academic Research OrganisationNovartis; Gilead SciencesRekrutteringHematopatologi Kvalifisert eller CAR-t-cellebehandlingFrankrike
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Har ikke rekruttert ennåAllogen, CAR-T, proteinsekvestrering, ikke-genredigertKina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Rekruttering
-
Shanghai International Medical CenterUkjentAvansert solid svulst | PD-1 antistoff | CAR-T-cellerKina
-
Ankara Yildirim Beyazıt UniversityRekruttering
-
Radboud University Medical CenterKU Leuven; University Hospital, Bonn; Clinica Universidad de Navarra, Universidad... og andre samarbeidspartnereRekrutteringPalliativ sedasjonTyskland, Nederland, Belgia, Italia, Spania
-
University Hospital, CaenRekruttering
-
Charite University, Berlin, GermanyKing's College Hospital NHS Trust; National and Kapodistrian University... og andre samarbeidspartnereTilbaketrukket
Kliniske studier på Technology-Enhanced Transitional Palliative Care
-
University of North Carolina, CharlotteNational Heart, Lung, and Blood Institute (NHLBI)FullførtUkontrollert hypertensjonForente stater
-
Brown UniversityNational Institute on Drug Abuse (NIDA); University of Washington; UConn... og andre samarbeidspartnereAktiv, ikke rekrutterendeOpioidbruksforstyrrelseForente stater